Wells Fargo & Company Nexgel, Inc. Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
A detailed history of Wells Fargo & Company transactions in Nexgel, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 35 shares of NXGL stock, worth $104. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35
Previous 35
-0.0%
Holding current value
$104
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding NXGL
# of Institutions
14Shares Held
155KCall Options Held
0Put Options Held
0-
Simon Quick Advisors, LLC35.7KShares$106,7870.01% of portfolio
-
Geode Capital Management, LLC Boston, MA30.3KShares$90,5190.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny25.6KShares$76,6360.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA25.5KShares$76,3220.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il15.4KShares$45,9890.0% of portfolio
About NEXGEL, INC.
- Ticker NXGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 5,572,230
- Market Cap $16.7M
- Description
- NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was...